Name: Mirum Pharmaceuticals, Inc. (MIRM) Financial Statements
Creator: FinSpry

Mirum Pharmaceuticals Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Mirum Pharmaceuticals, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Revenue & Gross Profit
Revenue	336.89	186.37	77.06	19.14	0.00	0.00
Cost of Revenue	81.64	47.04	12.37	1.90	0.00	0.00
Gross Profit	255.25	139.34	64.69	17.24	0.00	0.00
Operating Expenses
Research & Development	140.63	102.61	106.84	131.43	81.61	42.99
Selling, General & Administrative	202.22	145.88	89.07	59.22	22.69	11.75
Operating Expenses	342.85	248.49	195.91	192.55	104.30	54.74
Operating Income	-87.61	-109.15	-131.22	-173.41	-104.30	-54.74
Other Income/Expense
Interest Income	13.79	13.74	3.86	0.37	1.56	0.00
Interest Expense	14.31	-15.11	-15.98	-17.59	-0.34	0.00
Other Income/Expense	1.21	-4.62	1.27	0.58	-0.19	0.02
Income
Income Before Tax	-86.91	-162.42	-142.07	-83.95	-103.26	-52.53
Income Tax Expense	1.03	0.99	-6.41	0.04	0.01	0.02
Net Income	-87.94	-163.42	-135.67	-83.99	-103.27	-52.55
Net Income - Continuous Operations	-87.94	-163.42	-135.67	-83.99	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	-48.97	-98.33	-127.98	-65.77	-103.99	-52.53
EBIT	-72.60	-109.15	-131.22	-83.95	-104.30	-52.53
Depreciation & Amortization	23.63	10.83	3.24	0.30	0.31	0.00
Earnings Per Share
Basic EPS	-2.00	-4.00	-4.00	-3.00	-4.00	-
Diluted EPS	-2.00	-4.00	-4.00	-3.00	-4.00	-5.00
Basic Shares Outstanding	47.52	40.89	33.84	30.32	25.25	11.49
Diluted Shares Outstanding	47.52	40.89	33.98	30.32	25.25	11.49